PLUS1
Best deals to access real time data! |
|
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
$29.56
|
|
London Stock Exchange Level 2
Monthly Subscription
for only
$77.61
|
|
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
$88.69
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Astrazeneca | AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -38.00 | -0.61% | 6,177.00 | 6,219.00 | 6,169.00 | 6,212.00 | 6,215.00 | 03:26:04 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 6,175.00 | 6,178.00 | 3.00 | 0.05% | 1 | 1 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 574 | 64,251 | 6,192.56p | 3,978,781p | - | 5,110.00 - 6,540.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 03:25:50 | AT | 148 | 6,177.00p | GBX |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
Astrazeneca Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| 81.53Bp | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | -p | 0.00% | - | - |
Astrazeneca News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/17/2019 | 02:00 | UK Regulatory (RNS & others) | AstraZeneca PLC Calquence significantly prolonged the time.. |
| 6/17/2019 | 01:55 | Alliance News |  AstraZeneca Cancer Drug Calquence Improves Progression Free.. |
| 6/14/2019 | 07:17 | Alliance News | AstraZeneca Drug Lokelma Effectively Treats Hyperkalaemia In.. |
| 6/12/2019 | 11:45 | UK Regulatory (RNS & others) | AstraZeneca PLC Publication of a Prospectus |
| 6/10/2019 | 22:40 | Dow Jones News | Companies Turn to Internal Crowdsourcing to Pick Best New.. |
| 6/10/2019 | 09:01 | Dow Jones News | AstraZeneca: Farxiga Reduced Progression of Kidney Disease.. |
| 6/10/2019 | 01:35 | Dow Jones News | AstraZeneca: Diabetes Drug Helps Prevent Kidney.. |
Astrazeneca Discussion Forums - AZN
| Date | Time | Comments | Title |
|---|---|---|---|
| 3/29/2019 | 07:42 | - | https://twitter.com/cpcannon/status/1111647628163452929 Pitch: "https://tinyurl.com/y9shcxeh |
| 3/13/2019 | 09:20 | - | What a stupid company AZN... better sell while |
| 2/15/2019 | 12:39 | - | AZN buy 40.92 |
| 11/09/2018 | 05:52 | - | AZN- TD Ameritrade won’t let me copy, but |
| 6/07/2018 | 08:50 | - | Simply amazing ,but understandable that this Stock is |
| 5/31/2018 | 12:01 | - | P.S. Some EURO Investment group is giving AZN a |
| 4/27/2018 | 07:21 | - | P.S. The EMC is the European Medical Commission. |
| 4/27/2018 | 07:20 | - | Today, Friday April 27th the EMC has recommended |
| 4/25/2018 | 09:54 | - | [b][i][color=blue] No More Pricks!!! please! [/color][/i]– Quick Dissolvable |
| 4/24/2018 | 07:11 | - | Imfinzi and Tre. being tweaked per Company scientists! |
Historical AZN Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 6,061 | 6,247 | 6,041 | 6,175.1145 | 1M | 2M | 2M | 116 | 1.91% |
| 1 Month | 5,885 | 6,247 | 5,739 | 5,996.1462 | 1M | 3M | 2M | 292 | 4.96% |
| 3 Months | 6,345 | 6,523 | 5,626 | 5,981.1774 | 1M | 9M | 2M | -168 | -2.65% |
| 6 Months | 6,115 | 6,540 | 5,312 | 5,956.9001 | 490k | 9M | 2M | 62 | 1.01% |
| 1 Year | 5,399 | 6,540 | 5,110 | 5,894.8474 | 490k | 9M | 2M | 778 | 14.41% |
| 3 Years | 3,834.5 | 6,540 | 3,680 | 5,126.8950 | 380k | 15M | 2M | 2,342.5 | 61.09% |
| 5 Years | 4,340 | 6,540 | 3,680 | 4,801.9734 | 94k | 15M | 3M | 1,837 | 42.33% |
